PCG
BSX icon

Prosperity Consulting Group’s Boston Scientific BSX Stock Holding History

Prosperity Consulting Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$734K Buy
17,188
+5,668
+49% +$308K 0.03% 326
2026
Q1 		$723K Sell
11,520
-424
-4% -$33.9K 0.03% 293
2025
Q4 		$1.14M Buy
11,944
+816
+7% +$80K 0.05% 233
2025
Q3 		$1.09M Sell
11,128
-2,739
-20% -$284K 0.05% 237
2025
Q2 		$1.49M Buy
13,867
+4
+0% +$405 0.11% 172
2025
Q1 		$1.4M Buy
13,863
+86
+0.6% +$8.66K 0.11% 182
2024
Q4 		$1.23M Buy
13,777
+775
+6% +$68.2K 0.09% 201
2024
Q3 		$1.09M Buy
13,002
+3,810
+41% +$300K 0.09% 215
2024
Q2 		$708K Buy
9,192
+1,354
+17% +$99.1K 0.1% 148
2024
Q1 		$537K Buy
7,838
+1,242
+19% +$79.9K 0.07% 194
2023
Q4 		$381K Buy
6,596
+1,302
+25% +$69.5K 0.13% 134
2023
Q3 		$280K Buy
+5,294
New +$278K 0.13% 117

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Prosperity Consulting Group's BSX Position: Q2 2026 in Review

Prosperity Consulting Group increased its Boston Scientific (BSX) stake by 49% in Q2 2026, buying an estimated $308K and bringing the position to 17,188 shares worth $734K. The position accounts for 0.03% of the portfolio, ranked #326.

Prosperity Consulting Group first reported a position in BSX in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.49M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Prosperity Consulting Group held 17,188 shares of Boston Scientific worth $734K as of Q2 2026.
  • Prosperity Consulting Group bought 5,668 Boston Scientific shares in Q2 2026, an estimated $308K.
  • Boston Scientific made up 0.03% of Prosperity Consulting Group's portfolio in Q2 2026, its #326 holding.
  • Prosperity Consulting Group first reported a position in Boston Scientific in Q3 2023 and has held it in 12 quarters since.
  • Prosperity Consulting Group's Boston Scientific position peaked at $1.49M in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Prosperity Consulting Group's 13F filing for Q2 2026, filed 13 Aug 2026.